HB Wealth Management LLC lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 6.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,209 shares of the biotechnology company’s stock after purchasing an additional 70 shares during the quarter. HB Wealth Management LLC’s holdings in Axon Enterprise were worth $378,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently modified their holdings of the company. ICA Group Wealth Management LLC purchased a new position in Axon Enterprise in the fourth quarter valued at about $26,000. Trivant Custom Portfolio Group LLC acquired a new stake in shares of Axon Enterprise in the first quarter worth about $31,000. First PREMIER Bank acquired a new stake in Axon Enterprise in the 1st quarter worth approximately $33,000. BKM Wealth Management LLC bought a new stake in shares of Axon Enterprise during the 4th quarter worth $32,000. Finally, Blue Bell Private Wealth Management LLC acquired a new position in Axon Enterprise in the 1st quarter valued at $41,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity
In other Axon Enterprise news, insider Jeffrey C. Kunins sold 43,668 shares of the company’s stock in a transaction that occurred on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total value of $13,534,459.92. Following the completion of the transaction, the insider now directly owns 189,719 shares in the company, valued at approximately $58,801,506.86. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction on Friday, May 31st. The shares were sold at an average price of $281.72, for a total value of $279,747.96. Following the completion of the sale, the director now owns 4,553 shares in the company, valued at approximately $1,282,671.16. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 43,668 shares of Axon Enterprise stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $309.94, for a total value of $13,534,459.92. Following the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The disclosure for this sale can be found here. Over the last three months, insiders have sold 89,447 shares of company stock valued at $27,684,677. 5.70% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
View Our Latest Stock Analysis on AXON
Axon Enterprise Price Performance
Shares of AXON traded up $0.62 during mid-day trading on Friday, reaching $297.18. The company had a trading volume of 77,108 shares, compared to its average volume of 488,762. The company’s 50 day simple moving average is $294.68 and its 200 day simple moving average is $285.92. The company has a market capitalization of $22.43 billion, a price-to-earnings ratio of 86.71 and a beta of 0.95. Axon Enterprise, Inc. has a 1-year low of $175.37 and a 1-year high of $329.87. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.55 and a current ratio of 2.91.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.20. The company had revenue of $460.74 million during the quarter, compared to the consensus estimate of $441.57 million. Axon Enterprise had a net margin of 15.60% and a return on equity of 11.71%. The company’s revenue for the quarter was up 34.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.51 earnings per share. Analysts expect that Axon Enterprise, Inc. will post 2.35 EPS for the current year.
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- What Are Trending Stocks? Trending Stocks Explained
- Constellation Brands Stock Q1 2025: Crushing Anheuser-Busch?
- Consumer Discretionary Stocks Explained
- Qualcomm Stock Continues to Rise in the Face of Negative News
- What Are Dividends? Buy the Best Dividend Stocks
- Top 3 Summer Stocks with Solid Growth Opportunities
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.